References
Dearden CE (2009) T-cell prolymphocytic leukemia. Clin Lymph Myeloma 9(Suppl 3):S239–S243. doi:10.3816/CLM.2009.s.018
Kameoka J, Takahashi N, Noji H, Murai K, Tajima K, Kameoka Y et al (2012) T-cell prolymphocytic leukemia in Japan: is it a variant? Int J Hematol 95(6):660–667. doi:10.1007/s12185-012-1077-y
Dearden CE, Khot A, Else M, Hamblin M, Grand E, Roy A et al (2011) Alemtuzumab therapy in T-cell prolymphocytic leukemia: comparing efficacy in a series treated intravenously and a study piloting the subcutaneous route. Blood 118(22):5799–5802. doi:10.1182/blood-2011-08-372854
Krishnan B, Else M, Tjonnfjord GE, Cazin B, Carney D, Carter J et al (2010) Stem cell transplantation after alemtuzumab in T-cell prolymphocytic leukaemia results in longer survival than after alemtuzumab alone: a multicentre retrospective study. Br J Haematol 149(6):907–910. doi:10.1111/j.1365-2141.2010.08134.x
Acknowledgements
Funding was provided by the Science and Technology Bureau of Changzhou, Jiangsu Province, China (Grant No. CJ20130035), Changzhou High-Level Medical Talents Training Project (Grant No. 2016ZCLJ024), and 333 Project of Jiangsu Province, China (Grant No. BRA2015088).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have stared that they have no conflicts of interest.
Additional information
Guangquan Zhou and Bai He have contributed equally to this study.
Rights and permissions
About this article
Cite this article
Zhou, G., He, B., Chen, T. et al. Modified Hyper-CVAD Regimen Followed by Autologous Peripheral Blood Stem Cell Transplantation Successfully Treated Synchronous T-Cell Prolymphocytic Leukemia and Gastric Cancer in a 68-Year-Old Female. Indian J Hematol Blood Transfus 33, 434–435 (2017). https://doi.org/10.1007/s12288-016-0752-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12288-016-0752-1